# Matched Unrelated vs. Haploidentical Donor for Allogeneic Stem Cell Transplantation in Patients With Acute Leukemia

> **NCT04232241** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Universitätsklinikum Hamburg-Eppendorf** · enrollment: 167 (actual)

## Conditions studied

- Acute Myeloid Leukemia in Remission
- Acute Lymphoblastic Leukemia in Remission
- Myelodysplastic Syndromes

## Interventions

- **DRUG:** Allogeneic Stem Cell Transplantation

## Key facts

- **NCT ID:** NCT04232241
- **Lead sponsor:** Universitätsklinikum Hamburg-Eppendorf
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-11-14
- **Primary completion:** 2026-11-22
- **Final completion:** 2026-11-26
- **Target enrollment:** 167 (ACTUAL)
- **Last updated:** 2025-04-22

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04232241

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04232241, "Matched Unrelated vs. Haploidentical Donor for Allogeneic Stem Cell Transplantation in Patients With Acute Leukemia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04232241. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*